2 results match your criteria: "Avera McKenna University Health Center and Transplant Institute[Affiliation]"

Outcomes after Liver Transplantation with Steatotic Grafts: Redefining Acceptable Cutoffs for Steatotic Grafts.

Euroasian J Hepatogastroenterol

July 2022

Division of Hepatology, Department of Internal Medicine, Sandra Atlas Bass Center for Liver Diseases and Transplantation, Barbara and Zucker School of Medicine for Hofstra/Northwell Health, Manhasset, New York, United States of America.

Article Synopsis
  • Researchers studied liver graft macrosteatosis in over 26,000 transplant donors to redefine acceptable steatosis levels, categorizing them into high-risk (≥20%) and low-risk (<20%).
  • Results showed that low-risk steatotic grafts had significantly better graft survival rates (93.3% at 90 days) compared to high-risk groups, which led to worse outcomes as steatosis levels increased.
  • The findings propose a new classification system for liver grafts based on steatosis percentage, which can help assess risk and improve transplant outcomes.
View Article and Find Full Text PDF

Morbid obesity is considered a relative contraindication for liver transplantation (LT). We investigated if body mass index (BMI; lean versus obese) is a risk factor for post-LT graft and overall survival in nonalcoholic steatohepatitis (NASH) and non-NASH patients. Using the United Network for Organ Sharing (UNOS) database, LT recipients from January 2002 to June 2013 (age ≥18 years) with follow-up until 2017 were included.

View Article and Find Full Text PDF